LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk
暂无分享,去创建一个
S. Serrano | N. Malats | M. Kogevinas | M. Márquez | A. Carrato | A. Tardón | J. Lloreta | D. Silverman | N. Rothman | S. Chanock | F. Real | M. García-Closas | M. Fraga | J. Carles | R. Garcı́a-Closas | C. Serra | C. Murta-Nascimento | L. Palència | G. Vellalta | S. Tajuddin | J. Prat | J. Sanchez | L. Ibarz | B. Jackson | G. Carretero | L. Cecchini | M. Doménech | M. Torà | M. Céspedes | R. G. Urdinguio | E. G. Toraño | M. Ull | A. Mateos | A. Amaral | J. Mosquera | Á. Prera | Ó. Bielsa | C. Abad | R. Abascal | J. L. Guate | M. Diaz | M. Rivas | J. Fortuny | M. Sala | A. Fernández | C. Manzano | A. Castillejo | V. Frade | M. Arguelles | J. M. Saladie | E. Andrada | J. Badal | D. Puente | R. Hernando | J. Soto | A. Gelabert | A. Amorós | C. Villanueva | R. Jaramillo | G. Castaño | A. Herrero | K. Villadiego | L. Ferrer | C. Pravia | P. Muntañola | J. Taño | A. Cabezuelo | F. García-López | J. Malet | J. Velasco | J. Rodríguez | A. Bustos | J. M. Fernández | F. Cáceres | R García-Closas | M N F X M G M D C C J E S R G L F A A G J S L A J O Kogevinas Malats Real Sala Castaño Torà Puente | E. López | S. Hernández | F. Fermandez | A. Alfaro | D. Garcia | J. Pujadas | J. M. Rodríguez de Vera | A. Martin | A. Teruel | J. Lanzas | T. Miralles | O. González | Mieres Asturias | A. Huescar | F. Huergo | J. Sanchez | O. Bielsa | J. Saladie
[1] R. Gangnon,et al. Telomere Length and Pancreatic Cancer: A Case–Control Study , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[2] Peter A. Jones. Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.
[3] U. Capitanio,et al. Serum Sex Steroids Depict a Nonlinear U-Shaped Association with High-Risk Prostate Cancer at Radical Prostatectomy , 2012, Clinical Cancer Research.
[4] D. Silverman,et al. Correlation of LINE-1 Methylation Levels in Patient-Matched Buffy Coat, Serum, Buccal Cell, and Bladder Tumor Tissue DNA Samples , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[5] Jeongseon Kim,et al. Global DNA Hypomethylation in Peripheral Blood Leukocytes as a Biomarker for Cancer Risk: A Meta-Analysis , 2012, PloS one.
[6] C. Marsit,et al. LINE‐1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese , 2012, International journal of cancer.
[7] N. Malats,et al. Pancreatic cancer risk and levels of trace elements , 2011, Gut.
[8] Z. Bhujwalla,et al. Choline metabolism in malignant transformation , 2011, Nature Reviews Cancer.
[9] N. Rothman,et al. LINE-1 Methylation Levels in Leukocyte DNA and Risk of Renal Cell Cancer , 2011, PloS one.
[10] Jian Gu,et al. A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. , 2011, Human molecular genetics.
[11] F. Clavel-Chapelon,et al. A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. , 2011, European journal of cancer.
[12] R. Santella,et al. Global methylation profiles in DNA from different blood cell types , 2011, Epigenetics.
[13] M. Thun,et al. A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC 14 A 1 , a urea transporter gene on chromosome 18 q 12 . 3 , 2011 .
[14] P. Ueland. Choline and betaine in health and disease , 2011, Journal of Inherited Metabolic Disease.
[15] William Wheeler,et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci , 2010, Nature Genetics.
[16] C. Font,et al. Tobacco-related tumours of the lung, bladder and larynx: changes in Spain. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[17] Peter A. Jones,et al. Hypomethylation of a LINE-1 Promoter Activates an Alternate Transcript of the MET Oncogene in Bladders with Cancer , 2010, PLoS genetics.
[18] V. Zoumpourlis,et al. Environmental factors and genetic susceptibility promote urinary bladder cancer. , 2010, Toxicology letters.
[19] Rondi A. Butler,et al. Implications of LINE1 Methylation for Bladder Cancer Risk in Women , 2010, Clinical Cancer Research.
[20] P. Laird. Principles and challenges of genome-wide DNA methylation analysis , 2010, Nature Reviews Genetics.
[21] Peter A. Jones,et al. Epigenetics in cancer. , 2010, Carcinogenesis.
[22] H. Byun,et al. Changes in DNA methylation of tandem DNA repeats are different from interspersed repeats in cancer , 2009, International journal of cancer.
[23] S. Wallenstein,et al. Gene expression profiles of the one-carbon metabolism pathway. , 2009, Journal of genetics and genomics = Yi chuan xue bao.
[24] A. Mutirangura,et al. LINE-1 methylation patterns of different loci in normal and cancerous cells , 2008, Nucleic acids research.
[25] A. Neugut,et al. Choline metabolism and risk of breast cancer in a population‐based study , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] Debra Silverman,et al. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. , 2008, The Lancet. Oncology.
[27] W. Schulz,et al. Chromosomal instability in bladder cancer , 2008, Archives of Toxicology.
[28] D. Parkin,et al. The global burden of urinary bladder cancer , 2008, Scandinavian journal of urology and nephrology. Supplementum.
[29] N. Malats,et al. Screening for bladder cancer: a perspective , 2008, World Journal of Urology.
[30] D. Vance,et al. Hepatic Phosphatidylethanolamine N-Methyltransferase, Unexpected Roles in Animal Biochemistry and Physiology* , 2007, Journal of Biological Chemistry.
[31] Ivo G Gut,et al. DNA methylation analysis by pyrosequencing , 2007, Nature Protocols.
[32] R. Sinha,et al. Food, nutrient and heterocyclic amine intake and the risk of bladder cancer. , 2007, European journal of cancer.
[33] N. Malats,et al. Polymorphisms in one‐carbon metabolism and trans‐sulfuration pathway genes and susceptibility to bladder cancer , 2007, International journal of cancer.
[34] N. Malats,et al. Epidemiology of urinary bladder cancer: from tumor development to patient’s death , 2007, World Journal of Urology.
[35] J. Issa,et al. LINE-1 Hypomethylation in Cancer Is Highly Variable and Inversely Correlated with Microsatellite Instability , 2007, PloS one.
[36] Patrick Royston,et al. Multivariable Modeling with Cubic Regression Splines: A Principled Approach , 2007 .
[37] Nilanjan Chatterjee,et al. Large-Scale Evaluation of Candidate Genes Identifies Associations between VEGF Polymorphisms and Bladder Cancer Risk , 2007, PLoS genetics.
[38] N. Malats,et al. PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors. , 2006, Cancer research.
[39] Núria Malats,et al. Smoking and Bladder Cancer in Spain: Effects of Tobacco Type, Timing, Environmental Tobacco Smoke, and Gender , 2006, Cancer Epidemiology Biomarkers & Prevention.
[40] 司履生. Cancer epigenetics , 2006 .
[41] Xue-Ru Wu. Urothelial tumorigenesis: a tale of divergent pathways , 2005, Nature Reviews Cancer.
[42] N. Malats,et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses , 2005, The Lancet.
[43] Trygve O Tollefsbol,et al. The impact of metabolism on DNA methylation. , 2005, Human molecular genetics.
[44] M. Kogevinas,et al. NAT 2 slow acetylation , GSTM 1 null genotype , and risk of bladder cancer : results from the Spanish Bladder Cancer Study and meta-analyses , 2005 .
[45] P. Laird. Cancer epigenetics. , 2005, Human molecular genetics.
[46] B. Jackson,et al. Trophic and maternal transfer of selenium in brown house snakes (Lamprophis fuliginosus). , 2004, Ecotoxicology and environmental safety.
[47] J. Issa,et al. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. , 2004, Nucleic acids research.
[48] Pär Stattin,et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries , 2004, International journal of cancer.
[49] W. Schulz,et al. Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma. , 1996, Cancer research.